Irinotecan in combination with CDDP or5‐FU and folinic acid is active in patients with advanced gastric or gastro‐oesophageal junction adenocarcinoma:Final results of a randomized phase Ⅱ study .Analysis of biomarker expression(ki67,EGFR,HER2,ERK,NFk B,an ......